ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1090

CpG-Stimulated B Cells Require Glutaminolysis for Glycolysis, Mitochondrial Respiration, and Cytokine Production

Matthew Cheung1, Dongyue Huang1, Doujiao Wu2, Edward Pearce3 and Alfred Kim1, 1Rheumatology, Washington University School of Medicine, Saint Louis, MO, 2Pathology & Immunology, Washington University School of Medicine, Saint Louis, MO, 3Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: B cells, cytokines and metabolism

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: B Cell Biology and Targets in Autoimmune Disease - Poster I: SLE and Sjögren's

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  B cells contribute to disease pathophysiology through several mechanisms, including cytokine secretion. A wide variety of stimuli can activate B cells to produce cytokines including B cell receptor and Toll-like receptor engagement. Recently, numerous observations have established the role of metabolic pathways in the diverse array of immune cell functions. It is unknown though how these metabolic pathways influence B cell cytokine production. We sought to elucidate the metabolic programs required for B cell cytokine production.

Methods:  B cells were isolated from the spleens of C57Bl/6J mice and activated overnight individually by the following agents: anti-μ antibody, anti-CD40 agonist antibody, poly(I:C), LPS, loxoribine, and CpG. Supernatants were collected and analyzed for the quantification of cytokines using the Milliplex cytokine kit (EMD Millipore). Real-time analysis of extracellular acidification rates and oxygen consumption rates of activated B cells were performed using the XF-96 Extracellular Flux Analyzer (Seahorse Bioscience). Three or more consecutive measurements were obtained under basal conditions and after the sequential addition of 1 μM oligomycin, to inhibit mitochondrial ATP synthase; 1.5 μM FCCP (fluoro-carbonyl cyanide phenylhydrazone), a protonophore that uncouples ATP synthesis from oxygen consumption by the electron-transport chain; and 100 nM rotenone plus 1 μM antimycin A, which inhibit the electron transport chain. To assess 3-carbon sources for oxidative phosphorylation, inhibitors to fatty acid oxidation (etomoxir, which irreversibly inhibits carnitine palmitoyltransferase-1), pyruvate transfer to mitochondria (UK-5099), and glutamine usage (BPTES, which inhibits mitochondrial glutaminases) were used.

Results:  CpG stimulation of mouse splenic B cells increased both glycolysis and mitochondrial respiration to a larger extent that by other stimuli such as LPS or B cell receptor alone. These processes are highly dependent on glutamine, as inhibition of glutaminolysis with BPTES significantly reduced both processes. Importantly, production of TNF-α, IL-6, and IL-10 by CpG-stimulated B cells also heavily relied on glutaminolysis.

Conclusion: B cells undergo metabolic reprogramming when stimulated with CpG, requiring glutaminolysis. Cytokine production is intrinsically linked with this reprogramming. These data are the among first to demonstrate a relationship between B cell effector function and metabolic reprogramming, and suggest that B cell cytokine secretion can be manipulated by altering the local metabolic environment. Manipulating metabolic pathways may represent an interesting therapeutic approach for modulating B cells in autoimmune diseases.


Disclosure: M. Cheung, None; D. Huang, None; D. Wu, None; E. Pearce, None; A. Kim, Kypha, Inc., 2,Amgen, 5,Janssen Pharmaceutica Product, L.P., 5,Pfizer Inc, 5.

To cite this abstract in AMA style:

Cheung M, Huang D, Wu D, Pearce E, Kim A. CpG-Stimulated B Cells Require Glutaminolysis for Glycolysis, Mitochondrial Respiration, and Cytokine Production [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/cpg-stimulated-b-cells-require-glutaminolysis-for-glycolysis-mitochondrial-respiration-and-cytokine-production/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cpg-stimulated-b-cells-require-glutaminolysis-for-glycolysis-mitochondrial-respiration-and-cytokine-production/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology